Wordt geladen...
Histone Deacetylase Inhibitors in the Treatment of Muscular Dystrophies: Epigenetic Drugs for Genetic Diseases
Histone deacetylases inhibitors (HDACi) include a growing number of drugs that share the ability to inhibit the enzymatic activity of some or all the HDACs. Experimental and preclinical evidence indicates that these epigenetic drugs not only can be effective in the treatment of malignancies, inflamm...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
ScholarOne
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105131/ https://ncbi.nlm.nih.gov/pubmed/21308150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00049 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|